Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 75 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

15%

11 trials in Phase 3/4

Results Transparency

1 of 12 completed trials have results

Key Signals

23 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

24(47.1%)

N/A

11(21.6%)

Phase 3

8(15.7%)

Phase 1

5(9.8%)

Phase 4

3(5.9%)

51Total

Phase 2(24)

N/A(11)

Phase 3(8)

Phase 1(5)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (75)

Showing 20 of 75 trials

NCT07646145Phase 2Recruiting

Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer

Role: lead

NCT07306390Not Yet Recruiting

Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)

Role: collaborator

NCT07162506Phase 2Recruiting

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Role: collaborator

NCT07038629Phase 2Recruiting

Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC

Role: collaborator

NCT05788029Not ApplicableEnrolling By Invitation

Comparing Laparoscopic and Open Pancreaticoduodenectomy for Nonpancreatic Periampullary Adenocarcinomas

Role: collaborator

NCT07586826Phase 2Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Role: collaborator

NCT07586813Phase 2Recruiting

Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors

Role: collaborator

NCT07569055Recruiting

Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Role: collaborator

NCT07489339Not ApplicableCompleted

MDT-Based Nursing for Small Cell Lung Cancer During Chemo-Immunotherapy

Role: lead

NCT07498972Not ApplicableCompleted

Evidence-Based Nursing Plus Progressive Exercise for Cancer-Related Fatigue in Advanced Lung Cancer

Role: lead

NCT07490639Not ApplicableCompleted

Family-Supported Palliative Care in Advanced Lung Cancer

Role: lead

NCT07486648Phase 1Not Yet Recruiting

Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib

Role: lead

NCT07370116Phase 2Not Yet Recruiting

Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy

Role: collaborator

NCT07454941Enrolling By Invitation

Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

Role: collaborator

NCT05787522Completed

Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk

Role: collaborator

NCT07390565Not ApplicableEnrolling By Invitation

YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

Role: collaborator

NCT07383285Phase 2Not Yet Recruiting

CAPOX and Bevacizumab With or Without Primary Tumor Radiotherapy and Iparomlimab and Tuvonralimab as First-line Treatment for RAS-Mutant/MSS Metastatic Rectal Cancer

Role: collaborator

NCT03012971Not ApplicableCompleted

Dexmedetomidine Supplemented Analgesia and Long-term Survival After Cancer Surgery

Role: collaborator

NCT03012984Not ApplicableCompleted

Dexmedetomidine Supplemented Analgesia and Incidence of Postoperative Delirium

Role: collaborator

NCT07237828Not ApplicableNot Yet Recruiting

Drain Removal on Postoperative Safety and Patient Satisfaction in R-E-NSM With Prepectoral DIBR

Role: collaborator